ABOUT CDT PHARMA STRATEGIES
We bring decades of deep and broad pharmaceutical experience over a wide spectrum of therapeutic areas to clients of all sizes.
CDT Pharma Strategies is a boutique management consulting firm founded to address a critical need in Channel, Trade and Distribution strategies and execution. CDT fills a growing need as one of the only remaining independent & unaffiliated management consulting firms. We assist our manufacturer clients in the strategic design and execution of market access pathways, channel programs, distribution solutions and trade analytics that support breakthrough product access solutions and real world, hands on implementation support and strategy execution. We assist pharmaceutical manufacturers with, a multi-layered leadership view, associated long and short-term strategies, cost-effective executions and holistic, real-world viewpoints and approaches. All with a razor-sharp focus on outcomes and consistent high-performance.
CDT is driven to align strategic needs with operational and technological solutions across all key stakeholders. Including the teams outside of channel, trade and distribution – such as managed markets, commercial teams, sales and contract operations, patient support services/HUB and payer and reimbursement teams. We make sure the impact of our decisions enhance the entire product and patient journey ecosystem.
our team
Meet our Founder and President, Paul Callahan
Ron Krawczyk, Vice President Strategic Accounts
Ron Krawczyk, Vice President Strategic Accounts
Paul’s experience spans over three decades as a successful life sciences executive. Whether providing commercial leadership while working for industry giants such as Johnson & Johnson (Centocor) , EMD Serono, Sanofi-Aventis (RPR) and Specialty Pharmaceutical start-up companies such as Cell Therapeutics (CTI Biopharma) and Solstice Neuros
Paul’s experience spans over three decades as a successful life sciences executive. Whether providing commercial leadership while working for industry giants such as Johnson & Johnson (Centocor) , EMD Serono, Sanofi-Aventis (RPR) and Specialty Pharmaceutical start-up companies such as Cell Therapeutics (CTI Biopharma) and Solstice Neurosciences, or, delivering tested solutions and consultation to the clients of Blue Fin Group and Protean LLC, Paul’s expertise spans the full range of pharmaceutical, commercial and financial organizations.
Ron Krawczyk, Vice President Strategic Accounts
Ron Krawczyk, Vice President Strategic Accounts
Ron Krawczyk, Vice President Strategic Accounts
Ron has over 38 years of experience in the areas of US and OUS pharmaceutical, biotech, biosimilars, generic, and medical device sales, commercial operations, global supply chain planning and execution, distribution, and logistics policy and program development.
Ron has held the position of Vice President, Business Operations at Johnson &
Ron has over 38 years of experience in the areas of US and OUS pharmaceutical, biotech, biosimilars, generic, and medical device sales, commercial operations, global supply chain planning and execution, distribution, and logistics policy and program development.
Ron has held the position of Vice President, Business Operations at Johnson & Johnson, where he was responsible for the development and implementation of corporate channel strategy, including distribution services and trade partnership management for an $18 billion sales portfolio. Ron has also served in general management, sales management and product management roles for Fortune 500 and start-up companies, such as Rhone Poulenc, Canada, Rhone Poulenc Rorer, Arcola Labs, and Centocor.
Ron earned a BSC degree from the University of Windsor, Windsor Ontario, Canada.